Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-06 4:07 pm Sale |
2024-12-31 | 13G | COMPASS Pathways plc CMPS |
Integrated Core Strategies (US) LLC | 3,413,448 3.700% |
-473,753![]() (-12.19%) |
Filing History |
2025-01-30 4:00 pm Sale |
2024-12-31 | 13G | Accolade, Inc. ACCD |
Integrated Core Strategies (US) LLC | 3,090,861 3.800% |
-999,481![]() (-24.44%) |
Filing History |
2025-01-28 4:00 pm Sale |
2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Integrated Core Strategies (US) LLC | 1,994,503 3.500% |
-954,373![]() (-32.36%) |
Filing History |
2025-01-27 4:00 pm Sale |
2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
Integrated Core Strategies (US) LLC | 6,292,634 4.300% |
-3,107,939![]() (-33.06%) |
Filing History |
2025-01-22 4:01 pm Purchase |
2025-01-14 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
Integrated Core Strategies (US) LLC | 1,382,273 6.500% |
1,382,273![]() (New Position) |
Filing History |
2024-12-16 4:04 pm Purchase |
2024-12-09 | 13G | Pyxis Oncology, Inc. PYXS |
Integrated Core Strategies (US) LLC | 3,160,139 5.300% |
3,160,139![]() (New Position) |
Filing History |
2024-11-13 4:28 pm Sale |
2024-09-30 | 13G | Plum Acquisition Corp. III PLMJ |
Integrated Core Strategies (US) LLC | 0 0.000% |
-1,324,566![]() (Position Closed) |
Filing History |
2024-11-12 4:19 pm Sale |
2024-09-30 | 13G | Vapotherm, Inc. VAPO |
Integrated Core Strategies (US) LLC | 0 0.000% |
-490,044![]() (Position Closed) |
Filing History |
2024-11-12 4:15 pm Sale |
2024-11-07 | 13G | Avid Bioservices, Inc. CDMO |
Integrated Core Strategies (US) LLC | 880,968 1.400% |
-3,359,179![]() (-79.22%) |
Filing History |
2024-11-07 4:25 pm Sale |
2024-09-30 | 13G | NETSTREIT Corp. NTST |
Integrated Core Strategies (US) LLC | 3,825,273 4.700% |
-78,168![]() (-2.00%) |
Filing History |
2024-11-07 4:21 pm Sale |
2024-09-30 | 13G | Embecta Corp. EMBC |
Integrated Core Strategies (US) LLC | 2,444,823 4.200% |
-1,191,125![]() (-32.76%) |
Filing History |
2024-11-06 4:08 pm Purchase |
2024-10-31 | 13G | PHINIA Inc. PHIN |
Integrated Core Strategies (US) LLC | 2,272,842 5.400% |
2,272,842![]() (New Position) |
Filing History |
2024-11-05 4:15 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Integrated Core Strategies (US) LLC | 1,628,534 1.900% |
-1,851,096![]() (-53.20%) |
Filing History |
2024-11-05 4:11 pm Sale |
2024-09-30 | 13G | Utz Brands, Inc. UTZ |
Integrated Core Strategies (US) LLC | 2,805,867 3.400% |
-1,383,200![]() (-33.02%) |
Filing History |
2024-11-04 4:07 pm Sale |
2024-09-30 | 13G | Sutro Biopharma, Inc. STRO |
Integrated Core Strategies (US) LLC | 2,031,745 2.500% |
-1,420,080![]() (-41.14%) |
Filing History |
2024-11-01 4:05 pm Purchase |
2024-10-28 | 13G | Astria Therapeutics, Inc. ATXS |
Integrated Core Strategies (US) LLC | 2,948,876 5.200% |
2,948,876![]() (New Position) |
Filing History |
2024-10-31 4:23 pm Sale |
2024-09-30 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 4,192,865 4.000% |
-1,556,150![]() (-27.07%) |
Filing History |
2024-10-29 4:30 pm Purchase |
2024-09-30 | 13G | Milestone Pharmaceuticals Inc. MIST |
Integrated Core Strategies (US) LLC | 2,778,525 5.200% |
1,047,636![]() (+60.53%) |
Filing History |
2024-10-16 4:43 pm Purchase |
2024-09-30 | 13G | Cryoport, Inc. CYRX |
Integrated Core Strategies (US) LLC | 3,730,516 7.500% |
913,417![]() (+32.42%) |
Filing History |
2024-10-11 4:14 pm Purchase |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Integrated Core Strategies (US) LLC | 9,400,573 6.400% |
1,650,440![]() (+21.30%) |
Filing History |